# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jim Cramer discusses Snowflake, Royalty Pharma, Core Scientific and Ally Financial on "Mad Money Lightning Round."
Ally Financial reported an earnings beat, driven by higher electric vehicle originations. Credit guidance is disappointing.
Morgan Stanley analyst Betsy Graseck maintains Ally Financial (NYSE:ALLY) with a Overweight and raises the price target from...
Wells Fargo analyst Donald Fandetti maintains Ally Financial (NYSE:ALLY) with a Underweight and raises the price target from...
Barclays analyst Jason Goldberg maintains Ally Financial (NYSE:ALLY) with a Equal-Weight and raises the price target from $4...
RBC Capital analyst Jon Arfstrom maintains Ally Financial (NYSE:ALLY) with a Outperform and raises the price target from $46...
It’s deep red on Wall Street on Wednesday, with tech stocks sharply falling amid a semiconductor broad-based selloff following ...
Sentiment will likely reverse course, with the index futures trading notably lower early Wednesday. The recent run-up ideally s...